HHLR Advisors’s 10x Genomics TXG Stock Holding History

HHLR Advisors’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-75,000	Closed	-$10.6M	–	100
2020 Q4	$10.6M	Hold	75,000	–	–	0.08%	73
2020 Q3	$9.35M	Hold	75,000	–	–	0.07%	64
2020 Q2	$6.7M	Hold	75,000	–	–	0.06%	61
2020 Q1	$4.67M	Hold	75,000	–	–	0.06%	53
2019 Q4	$5.72M	Hold	75,000	–	–	0.07%	49
2019 Q3	$3.78M	Buy	+75,000	New	+$4.15M	0.05%	56

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

MCAV

Meritech Capital Associates V Palo Alto, California $141M AUM 15.44% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

HHLR Advisors's TXG Position: Q1 2021 in Review

HHLR Advisors sold out of 10x Genomics (TXG) in Q1 2021, closing a stake of 75,000 shares — an estimated $10.6M sold.

HHLR Advisors first reported a position in TXG in Q3 2019 and held it in 6 quarters. The position peaked at $10.6M in Q4 2020. 324 funds tracked by Wall St. Rank hold TXG as of Q1 2021.

HHLR Advisors reported no remaining 10x Genomics position as of Q1 2021 after selling out during the quarter.
HHLR Advisors sold 75,000 10x Genomics shares in Q1 2021, an estimated $10.6M.
HHLR Advisors first reported a position in 10x Genomics in Q3 2019 and held it in 6 quarters.
HHLR Advisors's 10x Genomics position peaked at $10.6M in Q4 2020.
324 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2021.

Based on HHLR Advisors's 13F filing for Q1 2021, filed 17 May 2021.